STORY AT-A-GLANCE

  • February 1, 2022, Pfizer/BioNTech asked the U.S. Food and Drug Administration to grant emergency use authorization (EUA) for their COVID shot to babies and children aged 6 months through 4 years
  • The EUA will be for a two-dose regimen, with the possibility of extending it to a third dose, as two injections have been shown to be ineffective in 2- to 4-year-olds
  • Children aged 6 months to 4 years will get a dose that is one-tenth the adult dose
  • Were Pfizer to wait until the triple-dose experiment is completed, the EUA request would not be possible until late March 2022, and federal officials are reportedly “anxious to begin a vaccination program for the youngest children because the studies showed there were no safety concerns with two doses”
  • Meanwhile, Pfizer’s own data raise massive safety concerns, as they received 42,086 injury reports, including 1,223 fatalities in the first 2.5 months of their COVID jab rollout for adults

Complete article at 1st comment attached……………….